Summary Mutagenicity and cytotoxicity are basic cellular effects of cigarette smoke which underlie the development of lung cancer and chronic obstructive airways disease. This study reports that, on a weight-forweight basis, cigarette smoke condensates from low, middle and high tar cigarettes produce similar mutagenic effects detected by induced sister chromatid exchanges and similar cytotoxic effects detected by vital dye exclusion in human leucocytes. These findings, taken with the strong evidence that smokers extract more smoke from lower tar cigarettes to compensate for low nicotine yields, suggest that the health dangers associated with smoking these "safer" products are underestimated.
One strategy for diminishing the risk of disease associated with cigarette smoking has been the production of lower tar cigarettes, on the basis that it is this tar or condensate fraction which contains tumour initiators, promoters and other harmful substances (Wynder & Hoffman 1967; Wald et al., 1981) . Doubts about the safety of these lower tar products have been recently expressed, based on the demonstration by a number of groups (Vesey et al., 1982 , Ho-yen et al., 1982 , Sutton et al., 1982 and Benowitz et al., 1983 ) that smokers tend to compensate or extract more smoke from lower tar cigarettes by altered inhaling patterns in an attempt to satisfy demand for nicotine and also possibly tar. Despite the improvements in lung cancer rates in younger men that have accompanied the introduction of lower tar cigarettes, these recent doubts have led influential opinion to state that "despite seductive advertisements, there is no less hazardous, safer cigarette' (Lenfant, 1983) . One important practical aspect of this issue of compensated smoking is however, whether or not the toxic quality of smoke from these different cigarettes is similar to conventional cigarettes. There are grounds to consider whether the altered tobacco packing, the differences in wrapping paper and the presence of filter (all part of the production of the lower tar cigarette) may influence the quality of smoke, perhaps by a change in combustion temperature. Another unresolved issue on style of cigarette smoking is whether the association of relighting cigarettes (Dark et al., 1963) and of length to which cigarettes are smoked (Doll et al., 1959) with increased lung cancer risk simply reflects high consumption of smoke or suggests that the smoke products of the "tail end" of the cigarette are more toxic. This paper describes a study of the condensates from different tar and filter categories of popular British cigarettes in inducing two events in human cells in vitro -mutagenicity (assessed by sister chromatid exchange induction) and cytotoxicity (assessed by vital dye exclusion). We have previously shown that cigarette smoke is a potent inducer of both events in human cells in vitro and, further, that reproducible variation in individuals' responses can be clearly related to risk of developing disease (Hopkin & Evans 1979 Hopkin et al., 1981) . Lung cancer is associated with increasing levels of induced sister chromatid exchanges (SCE) and chronic bronchitis and emphysema with increasing levels of cell death. These earlier findings are in keeping with the hypotheses that for lung cancer, induced DNA change of unidentified type forms the basis of malignant transformation (Boveri, 1929) , and for chronic bronchitis and emphysema, that proteolytic enzymes released from polymorphs killed by cigarette smoke digest lung tissue leading to emphysema (Blue & Janoff, 1978) . These findings on SCEs, are in keeping with other evidence that, whilst SCEs are not in themselves mutations, they provide a good method for assessment of exposure of cells to mutagens (Perry & Evans, 1975 , Kato & Shimada, 1975 .
Materials and methods
Cigarette smoke condensate (CSC) was produced on an automatic smoking apparatus and cigarettes were smoked to standard butt length (Hopkin & Evans, 1979 Assessment of mutagenicity (Hopkin & Evans, 1979) (Sato et al., 1977) . These findings are particularly relevant to the series of studies now published which show clearly that smokers presented with fewer cigarettes or low tar cigarettes alter their puffing and inhaling habits to compensate almost completely for lowered nicotine and possibly tar yields (Vesey et al., 1982 , Ho-yen et al., 1982 Sutton et al., 1982; Benowitz et al., 1983) . Taken together these results suggest that the ill-effects of smoking lower tar cigarettes will be more severe in terms of lung cancer and chronic bronchitis than the simple labels of middle and low tar suggest and we believe that trends for mortality for lung cancer in Britain and epidemiological studies of chronic air flow obstruction support these doubts about the safety of the lower tar cigarettes. A large-scale conversion to filter cigarettes beginning in the early 1970s has been associated by the 1980s with a significant decline in deaths from lung cancer in younger males, but with no overall change in the number of deaths, and a progressively rising mortality rate for all ages of women, (Office of Population Censuses and Surveys 1980, 1981) . This is certainly in great contrast to the results of the British doctors' study (Doll & Peto 1976) , which showed that cessation of smoking led within 12 years to a four fifths reduction in the risk of developing lung cancer.
Large scale pulmonary function studies in Britain (Higgenbotham et al., 1980) and America (Sparrow et al., 1983) have shown that the tar category of cigarette smoked is irrelevant to decline in pulmonary function leading the authors to speculate that the gaseous phase may be more important than the tar or condensate phase in this respect. Our results suggest that these disappointing trends simply reflect the unaltered cytotoxic potential of cigarette smoke condensate and the propensity of smokers to puff and inhale these low tar cigarettes more vigously.
We conclude that whilst the introduction of "safer" lower tar products has made some useful contribution, other measures are urgently required to stem what is still an epidemic of lung cancer, chronic bronchitis and emphysema related to cigarette smoking.
